Building Targeted Chemotherapies: ADCs, ProTides And ‘Click Chemistry’

 
• By Ben Comer
  
Howard Skipper, early cancer chemotherapy researcher
Early Chemotherapy Researcher Howard Skipper

More from Innovation

More from In Vivo